Costly drugs may see sales boost with new Medicare benefit

02/24/2004 | Wall Street Journal, The

Drug makers will likely enjoy increased sales of their most expensive drugs when a Medicare drug benefit becomes available in 2006. Ninety-five percent of annual drug costs above $5,100 will be covered by the new program, meaning drugs like Amgen's Enbrel, a new treatment for rheumatoid arthritis that costs up to $1,100 monthly, will be within reach of qualifying seniors.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA